OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.26 USD
+0.04 (3.28%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.26 0.00 (0.00%) 5:42 PM ET
4-Sell of 5 4
C Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.26 USD
+0.04 (3.28%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.26 0.00 (0.00%) 5:42 PM ET
4-Sell of 5 4
C Value D Growth C Momentum D VGM
Zacks News
Abiomed's (ABMD) Preliminary Q3 Results Cheer Investors
by Zacks Equity Research
Abiomed (ABMD) raises its fiscal 2019 guidance. The company also expects to see strong contribution from its core Impella product line.
Here's Why Investors Should Hold Luminex (LMNX) Stock Now
by Zacks Equity Research
Luminex (LMNX) gains from strength in the Aries platform. However, cutthroat competition in the life sciences industry is worrisome.
Here's Why Investors Should Hold DENTSPLY (XRAY) Stock Now
by Zacks Equity Research
DENTSPLY (XRAY) gains from strength in CAD/CAM dental imaging platform. However, sluggishness in the European business is worrisome.
Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M
by Zacks Equity Research
The recent buyout is likely to contribute $40-$50 million to Luminex's (LMNX) revenues in 2019.
Here's Why You Should Invest in PerkinElmer (PKI) Stock Now
by Zacks Equity Research
Focus on emerging markets, improving margins and encouraging guidance provide PerkinElmer (PKI) a competitive edge in the MedTech space.
Here's Why You Should Invest in Wright Medical (WMGI) Now
by Zacks Equity Research
A bullish outlook and a wide array of products make Wright Medical (WMGI) a promising investment pick.
Ecolab Inks Deal With Clearway for Renewable Power Project
by Zacks Equity Research
Ecolab's (ECL) virtual power purchase agreement with Clearway is part of a broader trend among corporate buyers. This will cover the company???s annual domestic energy use completely.
Here's Why Investors Should Retain CONMED (CNMD) Stock Now
by Zacks Equity Research
CONMED's (CNMD) steady focus on innovation is indicative of brighter prospects ahead. The company faces cutthroat competition in the niche space.
Becton, Dickinson's MAX Enteric Viral Panel Cleared by FDA
by Zacks Equity Research
Becton, Dickinson's (BDX) Diagnostic Systems portfolio lends it a competitive edge.
Here's Why You Should Buy Intuitive Surgical (ISRG) Now
by Zacks Equity Research
A solid outlook for 2018 and strength in robotics make Intuitive Surgical (ISRG) a promising investment pick.
Varian Medical's (VAR) Halcyon Excluded From Trade Tariffs
by Zacks Equity Research
Recent trade war-related talks are likely to favor Varian Medical (VAR) in the long run.
Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now
by Zacks Equity Research
Plethora of developments for Becton, Dickinson (BDX); headwinds apprehended in fiscal 2019.
Integra Rides on Global Prospects, Hurt by Escalating Costs
by Zacks Equity Research
Integra LifeSciences (IART) aims at investment openings in the Asian market for a faster business boost than in the United States and also to flourish specific parts of its international businesses.
Quest Diagnostics (DGX) Divests India Business to Strand
by Zacks Equity Research
Quest Diagnostics (DGX) sees lucrative prospects in the U.S. diagnostic testing market.
Cala Health Picks Medidata Cloud for Observational Study
by Zacks Equity Research
Medidata's (MDSO) Cloud platform sees a slew of developments in recent times.
Inogen Gains From Commercial Launch of Wireless Connect
by Zacks Equity Research
Inogen's (INGN) expanding product portfolio lends it a competitive edge in the respiratory care devices market.
Here's Why You Should Hold HealthEquity (HQY) Stock for Now
by Zacks Equity Research
HealthEquity's (HQY) fiscal third-quarter results hold promise while competition is stiff.
Baxter Stock up on Launch of Disposable Curved Applicator
by Zacks Equity Research
Baxter's (BAX) wide array of surgical products see lucrative market prospects.
Here's Why You Should Hold Cooper Companies (COO) Stock Now
by Zacks Equity Research
Cooper Companies' (COO) strong CVI segment favors the stock while a soft Fertility unit raises concern.
CONMED's Buffalo Filter Buyout Likely to be Accretive in 2020
by Zacks Equity Research
CONMED's (CNMD) comprehensive surgical smoke evacuation portfolio lends it a competitive edge in the industry.
Varian Medical's Eclipse Picked by Paul Scherrer Institute
by Zacks Equity Research
Varian Medical's (VAR) latest developments fortify its foothold in the global cancer therapeutics market.
Here's Why You Should Hold Baxter International (BAX) Now
by Zacks Equity Research
Baxter's (BAX) recent string of developments boost the stock while segmental softness is a concern.
Varian Medical ProBeam-Equipped Emory Center Opens in Georgia
by Zacks Equity Research
Varian Medical's (VAR) flagship ProBeam system has lucrative prospects.
Baxter & EFCNI Collaborate to Improve Care for Preterm Born
by Zacks Equity Research
Baxter's (BAX) latest move is likely to increase the use of Baxter's Numeta G13E triple-chamber PN product.
Here's Why You Should Invest in athenahealth (ATHN) Now
by Zacks Equity Research
A strong guidance and focus on big data-based health records system make athenahealth (ATHN) a solid investment pick.